Search Results

BioMidwest

Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform

Cleveland Diagnostics, Inc. announced the closing of over $75M in growth capital financing.

January 17, 2024

·

4 min read

BioMidwest

Masimo and Cleveland Clinic Collaborate to Improve Hospital Remote Care

Masimo, a leading global provider of medical technology and hospital automation solutions, and Cleveland Clinic, a nonprofit academic medical center, announced the launch of a new partnership centered around hospital-based remote patient monitoring, including TeleCritical Care.

June 27, 2024

·

10 min read

Biotech Bay

Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines

Anixa Biosciences, Inc., a clinical-stage biotechnology company focused on the treatment and prevention of cancer, announced that it has entered into a joint development agreement with Cleveland Clinic to develop novel vaccines for various cancer types.

May 8, 2024

·

5 min read

Drug Development

TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing

TFF Pharmaceuticals, Inc today announced that, in collaboration with Cleveland Clinic, the Company is advancing multiple multivalent universal influenza vaccines to protect against seasonal and pandemic viruses into preclinical testing.

May 20, 2024

·

7 min read

Genetown

Life Molecular Imaging and SOFIE announce Neuraceq® availability in Cleveland

Life Molecular Imaging and SOFIE Biosciences, a national US manufacturer and developer of PET radiopharmaceuticals, announce that the companies have expanded their strategic partnership and licensing agreement to provide and distribute Neuraceq® out of SOFIE’s radiopharmaceutical manufacturing site located in Cleveland, Ohio.

April 5, 2024

·

5 min read

BioMidwest

Cleveland Diagnostics Announces Prostate Cancer Awareness Month Campaign: ‘A PSA on PSA’

Cleveland Diagnostics, Inc., a leading commercial-stage biotechnology company, is launching its inaugural Prostate Cancer Awareness Campaign this September: ‘A PSA on PSA.’

August 30, 2023

·

3 min read

BioMidwest

Cleveland Diagnostics Opens New Facility Amid Growing Demand for IsoPSA® Test

Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, has opened a new, state-of-the-art facility.

June 28, 2023

·

3 min read

Business

Cleveland Diagnostics Announces Agreement with Quest Diagnostics to Expand Patient Access to IsoPSA® Prostate Cancer Testing

Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, today announced an agreement designed to expand patient access to Cleveland Diagnostics’ novel prostate cancer test, IsoPSA.

February 13, 2023

·

5 min read

Press Releases

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

September 10, 2024

·

5 min read

BioMidwest

Foundation for Sarcoidosis Research Partners to Host 30 Volunteer Patient Leaders at Unique In-Person Training at Cleveland Clinic

The Foundation for Sarcoidosis Research is honored to host its inaugural in-person training of FSR-GSCA Volunteer Patient Leaders from around the United States at Cleveland Clinic, the FSR Global Sarcoidosis Clinic Alliance Founding Member.

March 1, 2024

·

3 min read